Abstract 7055: Synergistic effects of HM97662 as an EZH1/2 dual inhibitor combined with DNA-damaging agents on malignant lung cancers harboring SMARCA4-deficiency.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Hanmi Pharmaceutical (South Korea)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148648540